Results 31 to 40 of about 268,545 (217)

Bone mineral density changes during use of progestin-only contraceptives: a rapid review of recent evidenceAJOG Global Reports at a Glance

AJOG Global Reports
Objective: The purpose of this paper is to consolidate existing evidence and identify knowledge and research gaps on the bone health effects of progestin-only oral contraception, injectables, hormonal intrauterine devices, and implants.
Blake Erhardt-Ohren, MPH, Ndola Prata, MD, MSc, Scott Rosenblum, MS   +2 more
doaj   +1 more source

The effect of Vigna unguiculata on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)

Healthcare in Low-resource Settings, 2023
Depot medroxyprogesterone acetate (DMPA) is a contraceptive method that prevents ovulation and reduces endometrial thickness. This study aimed to investigate the influence of Vigna unguiculata (VU) on estrogen receptor-α expression and endometrial ...
Rizki Fitrianingtyas, Indah Christiana, Ririn Handayani, Ernawati Anggraeni, Zaida Mauludiyah, Sholihatil Hidayati   +5 more
doaj   +1 more source

Hormonal Contraceptives: What if Exposed During Pregnancy?

Erciyes Medical Journal, 2019
Objective: Hormonal contraceptives are contraindicated in pregnancy. However, some women may become pregnant while using contraceptives to prevent pregnancy.
Duygun Altıntaş Aykan, Yusuf Ergün
doaj   +1 more source

Pregnancy‐ and lactation‐associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Pregnancy‐ and lactation‐associated osteoporosis (PLO) is a syndrome characterized by fragility fractures (most commonly vertebral, often multiple) occurring in late pregnancy or the early postpartum period. This position statement summarizes the current knowledge of PLO, and the recommended procedure for assessment, diagnosis and treatment ...
Peyman Hadji, Apostolos Athanasiadis, Maria‐Luisa Brandi, Marlene Chakhtoura, Manju Chandran, Frank Chervenak, Amos Grünebaum, Irene Lambrinoudaki, Willem F. Lems, Apostolos M. Mamopoulos, Eugene McCloskey, Rossella E. Nappi, Jessica Pepe, Jean‐Yves Reginster, René Rizzoli, Petra Stute, Şansın Tuzun, Amanda J. Vincent, Maria Belen Zanchetta, M. Carola Zillikens, Ioannis Kyvernitakis   +20 more
wiley   +1 more source

The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women

Disease Models & Mechanisms, 2018
The role of sex hormones in regulating immune responses in the female genital tract has been recognized for decades. More recently, it has become increasingly clear that sex hormones regulate susceptibility to sexually transmitted infections through ...
Jocelyn M. Wessels, Allison M. Felker, Haley A. Dupont, Charu Kaushic   +3 more
doaj   +1 more source

Assessing the quality of contraception‐related content on TikTok: A scoping review

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background In recent years, growing “hormone‐phobia” and distrust in the medical field has pushed young women to use TikTok, a social media platform featuring short videos, as a source of contraceptive‐related information. Yet a 2024 study found that only 19.4% of these videos were created by healthcare professionals. Objectives The purpose of
Swati L. Narayan, Rose Rasty, Maryam Zafar, Daniela A. Perez‐Chadid, Anil Nanda, Gloria A. Bachman   +5 more
wiley   +1 more source

Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper

International Journal of Gynecology &Obstetrics, EarlyView.
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Chiara Benedetto, Martha Gulati, Suvarna S. Khadilkar, Angela H. E. M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea R. Genazzani, Hema Divakar, Athena Poppas, on behalf of the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO)   +9 more
wiley   +1 more source

THE EFFECT OF MEDROXYPROGESTERONE ACETATE ON PREMATURE LABOR IN THE SHEEP

, 1985
The ability of medroxyprogesterone acetate to premature delivery delay was investigated in nine chronically catheterized pregnant sheep (125 to 130 days' gestation).
H. Y. TSENG, L. BURD, TOMASI, Aldo, A. SCOMMEGNA   +3 more
core   +1 more source

Lipomembranous panniculitis after subcutaneous medroxyprogesterone acetate injections used for buttocks augmentation in Africa

, 2021
© 2021 the International Society of DermatologyWe describe a series of four African women with lipomembranous panniculitis after subcutaneous injections of depot medroxyprogesterone acetate (DMPA), a synthetic progestin commonly used as a contraceptive ...
Soares-de-Almeida, Luís, Maia Silva, João Nuno, Roda, Ângela, Filipe, Paulo, Pinto, Ana   +4 more
core   +1 more source

Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for in vitro Fertilization-A Single-Center Non-inferiority Randomized Controlled Trial

Frontiers in Endocrinology, 2020
Object: Is it possible to use different progestins cotreatment with human menopausal gonadotrophin (hMG) in women with advanced endometriosis but normal ovulation during controlled ovarian hyperstimulation (COH) in vitro fertilization (IVF)?
Haiyan Guo, Jianghui Li, Xi Shen, Yanyan Cong, Yun Wang, Ling Wu, Bin Li, Hongyuan Gao, Meng Ma, Wei Zhang, Xiaoyan Mao, Yonglun Fu, Qifeng Lyu, Weiran Chai, Yanping Kuang   +14 more
doaj   +1 more source